Clinical Trial Update: Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and immunogenicity of CodaVax-RSV in seropositive and seronegative children; trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• CodaVax-RSV

Snippet

Sponsor: Codagenix, Inc | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: ACTIVE_NOT_RECRUITING